Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hepatitis; Hepatitis C | Phase 1/Phase 2 | ClinicalTrials |
| Lymphopenia; T-Lymphocytopenia, Idiopathic CD4-Positive | Phase 1/Phase 2 | ClinicalTrials |
| Sepsis; Toxemia | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Lymphopenia | Phase 2 | ClinicalTrials |
| Sepsis; Toxemia | Phase 2 | ClinicalTrials |
| HIV Infections | Phase 1 | ClinicalTrials |
| Hepatitis; Hepatitis C | Phase 1/Phase 2 | ClinicalTrials |
| Sepsis; Toxemia | Phase 2 | ClinicalTrials |
| Hepatitis; Hepatitis C | Phase 1/Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, B-Cell | Phase 4 | ClinicalTrials |
CONTENTS